Key result
High polygenic susceptibility to hypertension was associated with a 6.6% reduction in general cognitive ability score compared to low susceptibility (β -0.066; p<0.001).
Why the study?
Hypertension is heritable and linked to dementia risk, but whether higher polygenic susceptibility to hypertension leads to worse cognitive performance in middle-aged persons without dementia was unproven.
Does higher polygenic susceptibility to hypertension reduce cognitive performance in middle-aged persons without stroke or dementia?
Cross-Sectional (n=48,118)
Does higher polygenic susceptibility to hypertension reduce cognitive performance in middle-aged persons without stroke or dementia?
Effect estimate: β -0.066
p-value: p=<0.001
Higher polygenic susceptibility to hypertension is associated with worse cognitive performance in middle-aged adults without dementia, suggesting genetic predisposition to hypertension influences brain health early.
No practice change indicated; leaves open whether polygenic hypertension risk causally impairs cognition.
Background and Objectives Mounting evidence indicates that hypertension leads to a higher risk of dementia. Hypertension is a highly heritable trait, and a higher polygenic susceptibility to hypertension (PSH) is known to associate with a higher risk of dementia. We tested the hypothesis that a higher PSH leads to worse cognitive performance in middle-aged persons without dementia. Confirming this hypothesis would support follow-up research focused on using hypertension-related genomic information to risk-stratify middle-aged adults before hypertension develops. Methods We conducted a nested cross-sectional genetic study within the UK Biobank (UKB). Study participants with a history of dementia or stroke were excluded. We categorized participants as having low (≤20th percentile), intermediate, or high (≥80th percentile) PSH according to results of 2 polygenic risk scores for systolic and diastolic blood pressure (BP) generated with data on 732 genetic risk variants. A general cognitive ability score was calculated as the first component of an analysis that included the results of 5 cognitive tests. Primary analyses focused on Europeans, and secondary analyses included all race/ethnic groups. Results Of the 502,422 participants enrolled in the UKB, 48,118 (9.6%) completed the cognitive evaluation, including 42,011 (8.4%) of European ancestry. Multivariable regression models using systolic BP–related genetic variants indicated that compared with study participants with a low PSH, those with intermediate and high PSH had reductions of 3.9% (β −0.039, SE 0.012) and 6.6% (β −0.066, SE 0.014), respectively, in their general cognitive ability score (p < 0.001). Secondary analyses including all race/ethnic groups and using diastolic BP–related genetic variants yielded similar results (p < 0.05 for all tests). Analyses evaluating each cognitive test separately indicated that reaction time, numeric memory, and fluid intelligence drove the association between PSH and general cognitive ability score (all individual tests, p < 0.05). Discussion Among nondemented, community-dwelling, middle-aged Britons, a higher PSH is associated with worse cognitive performance. These findings suggest that genetic predisposition to hypertension influences brain health in persons who have not yet developed dementia. Because information on genetic risk variants for elevated BP is available long before the development of hypertension, these results lay the foundation for further research focused on using genomic data for the early identification of high-risk middle-aged adults.
No takes yet. Share an insight, caveat, or question.
Rivier et al. (2023) conducted a cross-sectional in Without stroke or dementia (n=48,118). High polygenic susceptibility to hypertension (≥80th percentile) vs. Low polygenic susceptibility to hypertension (≤20th percentile) was evaluated on General cognitive ability score (β -0.066, p=<0.001). High polygenic susceptibility to hypertension was associated with a 6.6% reduction in general cognitive ability score compared to low susceptibility (β -0.066; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: